Similar articles

• Imaging beta-amyloid burden in aging and dementia.

  Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O'Keefe G, Klunk WE, Mathis CA, Price JC, Masters CL, Villemagne VL. Rowe CC, et al. Neurology. 2007 May 15;68(20):1718-25. doi: 10.1212/01.wnl.0000261919.22630.ea. Neurology. 2007. PMID: 17502554
• Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.

  Ng SY, Villemagne VL, Masters CL, Rowe CC. Ng SY, et al. Arch Neurol. 2007 Aug;64(8):1140-4. doi: 10.1001/archneur.64.8.1140. Arch Neurol. 2007. PMID: 17698704
• Amyloid imaging with PET in early Alzheimer disease diagnosis.

  Rowe CC, Villemagne VL. Rowe CC, et al. Med Clin North Am. 2013 May;97(3):377-98. doi: 10.1016/j.mcna.2012.12.017. Med Clin North Am. 2013. PMID: 23642577 Review.
• Biopsy support for the validity of Pittsburgh compound B positron emission tomography with a twist.

  Klunk WE. Klunk WE. Arch Neurol. 2008 Oct;65(10):1281-3. doi: 10.1001/archneur.65.10.1281. Arch Neurol. 2008. PMID: 18852340 Free PMC article. No abstract available.
• Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus.

  Arbizu J, García-Ribas G, Carrió I, Garrastachu P, Martínez-Lage P, Molinuevo JL. Arbizu J, et al. Rev Esp Med Nucl Imagen Mol. 2015 Sep-Oct;34(5):303-13. doi: 10.1016/j.remn.2015.03.002. Epub 2015 Jun 20. Rev Esp Med Nucl Imagen Mol. 2015. PMID: 26099942 English, Spanish.